Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Amann

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Der Pathologe|November 6, 2010
[Calciphylaxis. A less well-known, clinically relevant disease]J D Strehl, V Brandenburg, C Forster, et al.
Journal of the American Society of Nephrology : JASN|January 16, 1999
Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failureJ Törnig, M L Gross, A Simonaviciene, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activityA Nabokov, K Amann, P Gassmann, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" modelS R Orth, G Odoni, K Amann, et al.
Circulation|November 1, 2000
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosisC P Tiefenbacher, T Bleeke, C Vahl, et al.
Kidney International|February 13, 1999
Endothelin receptor antagonists influence cardiovascular morphology in uremic ratsA V Nabokov, K Amann, S Wessels, et al.
Clinical Nephrology|August 28, 2003
Special characteristics of atherosclerosis in chronic renal failureK Amann, K Tyralla, M L Gross, et al.
Kidney International|June 2, 1998
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized ratsU Schwarz, K Amann, S R Orth, et al.
American Journal of Obstetrics and Gynecology|February 20, 2003
Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxiaR Trollmann, K Amann, E Schoof, et al.
Hypertension (Dallas, Tex. : 1979)|April 16, 1998
Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive ratsS R Orth, J P Esslinger, K Amann, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Der Pathologe|November 6, 2010
[Calciphylaxis. A less well-known, clinically relevant disease]J D Strehl, V Brandenburg, C Forster, et al.
Journal of the American Society of Nephrology : JASN|January 16, 1999
Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failureJ Törnig, M L Gross, A Simonaviciene, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activityA Nabokov, K Amann, P Gassmann, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" modelS R Orth, G Odoni, K Amann, et al.
Circulation|November 1, 2000
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosisC P Tiefenbacher, T Bleeke, C Vahl, et al.
Kidney International|February 13, 1999
Endothelin receptor antagonists influence cardiovascular morphology in uremic ratsA V Nabokov, K Amann, S Wessels, et al.
Clinical Nephrology|August 28, 2003
Special characteristics of atherosclerosis in chronic renal failureK Amann, K Tyralla, M L Gross, et al.
Kidney International|June 2, 1998
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized ratsU Schwarz, K Amann, S R Orth, et al.
American Journal of Obstetrics and Gynecology|February 20, 2003
Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxiaR Trollmann, K Amann, E Schoof, et al.
Hypertension (Dallas, Tex. : 1979)|April 16, 1998
Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive ratsS R Orth, J P Esslinger, K Amann, et al.
Pageof 16